Cerence and PATEO Bring Conversational AI to Indonesia’s First Connected Car from SAIC-GM-Wuling
BURLINGTON, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced […]
Aprea Therapeutics Appoints Michael A. Kelly to Board of Directors
BOSTON, Sept. 29, 2020 (GLOBE NEWSWIRE) — Aprea Therapeutics Inc., (NASDAQ: APRE), a clinical-stage biotechnology company focused on developing and […]
BioCardia Issued New Patent for Delivery of Cardiac Cell Therapy Through Wrist Artery
SAN CARLOS, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions […]
Neuronetics® Celebrates 500,000 Treatment Milestone for Greenbrook® TMS
MALVERN, Pa., Sept. 29, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, […]
JAMA Oncology Highlights Plinabulin’s Efficacy in Preventing Chemotherapy-Induced Neutropenia as a Monotherapy
NEW YORK, Sept. 29, 2020 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company […]
Integra LifeSciences Announces Definitive Agreement to Divest its Extremity Orthopedics Business to Smith+Nephew for $240 Million
PRINCETON, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today […]
Aqua Metals Receives Additional $1.5M Insurance Payment; Collections to Date Reach $21.8M
MCCARRAN, Nev., Sept. 29, 2020 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), which is […]
TCR² Therapeutics to Present at Jefferies Cell Therapy Virtual Summit
CAMBRIDGE, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline […]
